Other effector molecules being releases by the CTLs, such as interferon‐γ (IFN‐γ) and tumor necrosis factor α (TNF‐α), augment their cytotoxicity toward cancer cells [(Schoenborn and Wilson, 2007; Farhood et al., 2019)]. The gene discussed is TNF; the disease is cancer.